- PROFIT & LOSS
- BALANCE SHEET
- RETURN CALCULATOR
- CORPORATE ACTION
- SHAREHOLDING PATTERN
- QUARTERLY RESULT
| 2019 ( ₹ in Cr. ) | 2018 ( ₹ in Cr. ) | 2017 ( ₹ in Cr. ) | 2016 ( ₹ in Cr. ) | 2015 ( ₹ in Cr. ) | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | 43.36 | 47.17 | 64.96 | 86.39 | 98.59 |
| Other Income | 1.66 | 31.33 | 1.14 | 1.98 | 46.01 |
| Stock Adjustments | -0.81 | -4.09 | 3.09 | 0.65 | -12.17 |
| Total Income | 44.21 | 74.41 | 69.19 | 89.02 | 132.43 |
| EXPENDITURE : | |||||
| Raw Materials | 27 | 34.19 | 55.01 | 66.73 | 69.51 |
| Excise Duty | 0 | 0 | 0 | 1.07 | 0.92 |
| Power and Fuel Cost | 2.5 | 2.13 | 2.05 | 2.54 | 2.01 |
| Other Manufacturing Expenses | 4.48 | 3.55 | 3.9 | 4.43 | 8.12 |
| Employee Cost | 9.01 | 7.47 | 6.81 | 6.99 | 10.78 |
| Selling and Administration Expenses | 3.13 | 4.04 | 3.2 | 3.39 | 9.17 |
| Miscellaneous Expenses | 9.77 | 26.82 | 2.9 | 1.38 | 6.42 |
| Less: Preoperative Expenditure Capitalised | 0 | 0 | 0 | 0 | 0 |
| Profit before Interest, Depreciation and Tax | -11.68 | -3.8 | -4.67 | 2.5 | 25.51 |
| Interest and Financial Charges | 2.13 | 6.94 | 11.47 | 12.96 | 13.46 |
| Profit before Depreciation and Tax | -13.81 | -10.74 | -16.14 | -10.46 | 12.05 |
| Depreciation | 3.48 | 3.97 | 4.22 | 4.86 | 5.99 |
| Minority Interest before PAT | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -17.28 | -14.72 | -20.36 | -15.32 | 6.07 |
| Tax | 1.07 | 2.19 | -0.9 | -0.18 | -0.15 |
| Profit After Tax | -18.35 | -16.91 | -19.46 | -15.14 | 6.22 |
| Minority Interest after PAT | 0.52 | -0.17 | -0.37 | -1.11 | 0.04 |
| Profit/Loss of Associate Company | 0 | 0 | 0 | 0 | 0 |
| Profit after Minority Interest and P/L of Assoc. Co. | -18.87 | -16.74 | -19.09 | -14.03 | 6.18 |
| Adjustment below Net Profit | 0 | 0 | 0 | 0 | -3.26 |
| P and L Balance brought forward | -34.58 | -17.85 | 1.24 | 15.27 | 12.96 |
| Appropriations | 0 | 0 | 0 | 0 | 0.61 |
| P and L Bal. carried down | -53.45 | -34.58 | -17.85 | 1.24 | 15.27 |
| Equity Dividend | 0 | 0 | 0 | 0 | 0 |
| Preference Dividend | 0 | 0 | 0 | 0 | 0 |
| Corporate Dividend Tax | 0 | 0 | 0 | 0 | 0 |
| Equity Dividend (%) | 0 | 0 | 0 | 0 | 0 |
| Earning Per Share (Rs.) | 0 | 0 | 0 | 0 | 3.31 |
| Book Value | 8.06 | 16.03 | 20.73 | 30.96 | 38.47 |
| Extraordinary Items | 1.01 | 27.84 | 0 | 0 | 36.02 |
| 2019 ( ₹ in Cr. ) | 2018 ( ₹ in Cr. ) | 2017 ( ₹ in Cr. ) | 2016 ( ₹ in Cr. ) | 2015 ( ₹ in Cr. ) | |
|---|---|---|---|---|---|
| SOURCES OF FUNDS : | |||||
| Share Capital | 23.66 | 23.66 | 18.66 | 18.66 | 18.66 |
| Reserves and Surplus | -4.6 | 14.27 | 24.01 | 39.1 | 53.12 |
| Total Shareholders Funds | 19.06 | 37.93 | 42.67 | 57.76 | 71.78 |
| Secured Loans | 44.1 | 44.37 | 80.14 | 80.48 | 68.65 |
| Unsecured Loans | 2.76 | 15.12 | 15.03 | 0.92 | 0.39 |
| Total Debt | 46.86 | 59.49 | 95.17 | 81.4 | 69.04 |
| Minority Interest | -0.21 | -0.73 | -0.55 | 0 | 0.93 |
| Total Liabilities | 65.71 | 96.69 | 137.29 | 139.16 | 141.75 |
| APPLICATION OF FUNDS : | |||||
| Gross Block | 80.11 | 79.77 | 79.65 | 79.67 | 77.36 |
| Less: Accum. Depreciation | 43.05 | 34.88 | 31.04 | 27.06 | 22.8 |
| Net Block | 37.06 | 44.89 | 48.61 | 52.61 | 54.56 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 16.9 | 16.9 | 16.9 |
| Current Assets, Loans and Advances | |||||
| Inventories | 9.28 | 10.67 | 16.74 | 16.38 | 16.12 |
| Sundry Debtors | 24.83 | 24.28 | 53.78 | 67.96 | 88.69 |
| Cash and Bank Balance | 2.71 | 2.95 | 2.66 | 2.71 | 2.77 |
| Loans and Advances | 45.59 | 55.56 | 39.62 | 36.14 | 20.79 |
| Less: Current Liab. and Prov. | |||||
| Current Liabilities | 53.76 | 41.67 | 41.02 | 53.56 | 58.07 |
| Provisions | 0 | 0 | 0 | 0 | 0 |
| Net Current Assets | 28.65 | 51.79 | 71.78 | 69.63 | 70.3 |
| Miscellaneous Expenses not w/o | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 65.71 | 96.68 | 137.29 | 139.14 | 141.76 |
| Contingent Liabilities | 0 | 0 | 0.29 | 1.64 | 11.56 |
If I had made LUMPSUM investment of ₹ 1,00,000
in BAFNA PHARMACEUTICALS LTD.
Months ago
My investment would be worth
₹ 1,41,900
with a Gain of
41.90 %
